Metabolism and disposition of C14-bilirubin in congenital non-hemolytic jaundice.

نویسندگان

  • R SCHMID
  • L HAMMAKER
چکیده

In mammals, unconjugated bilirubin is rapidly cleared from the circulation and almost quantitatively excreted as a conjugate in the bile (2-4). The efficiency and rapidity of this process indicate that conjugation and subsequent biliary excretion represent the principal pathway of bilirubin disposition. If alternate pathways of bilirubin metabolism exist under physiologic conditions, their level of functional efficiency must be so low as to render detection difficult. When hepatic dysfunction causes interference with the efficiency of conjugation and excretion of bilirubin, however, resulting in hyperbilirubinemia, such alternate metabolic pathways may be expected to play a more important role in disposing of the accumulated pigment load (5). Moreover, when formation and hence biliary excretion of conjugated pigment is virtually abolished owing to an enzymatic defect in the hepatic conjugating apparatus, alternate pathways of bilirubin metabolism must assume the principal role in disposing of the bile pigment formed from the continuous breakdown of hemoglobin (6). Such metabolic anomalies associated with severe unconjugated hyperbilirubinemia exist as a rare congenital syndrome in man (Crigler-Najjar syndrome) (7, 8) and as a recessively inherited enzymatic defect in a mutant strain of Wistar rats (Gunn rats) (8, 9). In both instances, the level of unconjugated hyperbilirubinemia remains remarkably constant over months and years (8), indicating that a "steady state" has been established between pigment production and disposition. In the present investigation, a patient with congenital unconjugated hyperbilirubinemia and a group of hyperbilirubinemic Gunn rats were in-

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effect of phenobarbitone on plasma (14C)bilirubin clearance in patients with unconjugated hyperbilirubinaemia.

1. The clearance of a tracer dose of [14C]bilirubin from the plasma was studied in patients with Gilbert’s syndrome, congenital non-haemolytic jaundice, haemolytic jaundice and in normal subjects. Clearance was significantly impaired in the patients with Gilbert’s syndrome and in those with congenital non-haemolytic jaundice when compared with the normal subjects, and was normal in the patient ...

متن کامل

بررسی تاثیر کلوفیبرات بر زردی نوزادان

Abstract: Background: Hyperbilirubinemia is a common problem in newborn infants and may progress to kernicterus if not treated. The objective of this study was to determine the therapeutic effect of clofibrate in full-term healthy neonates with non-hemolytic hyperbilirubinemia. Material and method: A randomized clinical trial was performed on two groups of healthy full-term neonates with jau...

متن کامل

Intermittent versus continuous phototherapy for the treatment of non-hemolytic moderate hyperbilirubinemia in term infants: a randomized controlled trial

Background: Phototherapy is the most effective treatment for neonatal jaundice and intermittent phototherapy is as effective as continuous phototherapy but with fewer complications and more benefits. This study compared the hospital length of stay, duration of phototherapy and the reducing rate of total serum bilirubin after 24 and 36 hours of phototherapy in two groups. Methods: The current d...

متن کامل

Hemolytic Anemia and Other Side Effects of Para-amino Benzoic Acid in an 8-Year-Old Girl

Background: Para-amino benzoic acid (PABA) is an important ingredient used as a structure moiety in drugs with wide range of therapeutic uses; however, its safety and possible side effects in young children have not been determined. Case Presentation: An 8-year-old girl was admitted to the emergency department for paleness, jaundice, abdominal pain and nausea associated with Hemoglubin (Hb) =4...

متن کامل

فراوانی بیماری همولیتیک متعاقب تعویض خون در 96 نوزاد

Background: ABO incompatibility hemolytic disease of the newborn is a common cause of clinical jaundice and causes two-thirds of the hemolytic disease in newborns. This study was undertaken to determine the frequency of ABO incompatibility hemolytic disease and its complications in newborns undergoing exchange transfusion.Methods: This prospective and descriptive study was performed in jaundice...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Journal of clinical investigation

دوره 42  شماره 

صفحات  -

تاریخ انتشار 1962